Ethanolamine → HCID 67215441, compound

HRID 1983196Notes

Reaction equation

HRID 1983196 reaction equation
Cl[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][C:10]([C:13]3[C:14]([C:19]4[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=4)=[N:15][O:16][C:17]=3[CH3:18])=[N:11][N:12]=2)=[CH:4][N:3]=1.[CH2:25]([CH2:27][NH2:28])[OH:26]>>[CH3:18][C:17]1[O:16][N:15]=[C:14]([C:19]2[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=2)[C:13]=1[C:10]1[O:9][C:8]([C:5]2[CH:6]=[CH:7][C:2]([NH:28][CH2:27][CH2:25][OH:26])=[N:3][CH:4]=2)=[N:12][N:11]=1

Participants

3

Procedure

As described for example 136b, 2-chloro-5-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-pyridine (200 mg, 0.59 mmol) was converted using ethanolamine instead of morpholine to the title compound (126 mg, 59%) which was obtained as an off-white solid. MS: m/e=364.3 [M+H]+.

Sources & evidence

ORD record
ord-feedb2ca96814bd395b21d13e0e960a7
Source dataset
uspto-grants-2009_06
Patent number
US07541372B2

Reaction notes

Loading…